CC chemokine ligand 20 (CCL20) positively regulates collagen type I production in 3D skin equivalent tissues.

Bandow, Kenjiro; Smith, Avi; Watkins, Trishawna; Shenk, Sasha; Gerami-Naini, Behzad; Garlick, Jonathan A

Bandow, Kenjiro; Smith, Avi; Watkins, Trishawna; Shenk, Sasha; Gerami-Naini, Behzad; Garlick, Jonathan A.

Afiliação

Bandow K; Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, Massachusetts, USA.
Smith A; Division of Biochemistry, Department of Oral Biology and Tissue Engineering, Meikai University School of Dentistry, Saitama, Japan.
Watkins T; Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, Massachusetts, USA.
Shenk S; Division of Biochemistry, Department of Oral Biology and Tissue Engineering, Meikai University School of Dentistry, Saitama, Japan.
Gerami-Naini B; Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, Massachusetts, USA.
Garlick JA; Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, Massachusetts, USA.

Exp Dermatol ; 32(4): 379-391, 2023 04.

Article em En | MEDLINE | ID: mdl-36398464

Assuntos

Quimiocinas CC; Colágeno Tipo I; Humanos; Quimiocinas CC/metabolismo; Colágeno Tipo I/genética; Colágeno Tipo I/metabolismo; Ligantes; Pele/metabolismo; Fibroblastos/metabolismo; Miofibroblastos/metabolismo; Diferenciação Celular/fisiologia; Quimiocina CCL20/genética; Quimiocina CCL20/metabolismo; Células Cultivadas; Actinas/metabolismo

Palavras-chave

3D human tissues; fibroblasts; fibrosis; self-assembled skin equivalent; transforming growth factor beta 1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimiocinas CC / Colágeno Tipo I Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google